NFE2 抗体 (AA 20-373) (PE)
Our Local Distributor
北京 101111
Quick Overview for NFE2 抗体 (AA 20-373) (PE) (ABIN8016339)
抗原
See all NFE2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 20-373
-
原理
- Anti-NFE2 Antibody PE Conjugated
-
交叉反应 (详细)
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human NFE2 recombinant protein (Position: E20-D373).
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- NFE2 (Nuclear Factor (Erythroid-Derived 2), 45kDa (NFE2))
-
别名
- NFE2
-
背景
-
Background: Transcription factor NF-E2 45 kDa subunit is a protein that in humans is encoded by the NFE2 gene. Enables several functions, including WW domain binding activity, identical protein binding activity, and protein N-terminus binding activity. Contributes to cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including labyrinthine layer blood vessel development, negative regulation of bone mineralization, and negative regulation of syncytium formation by plasma membrane fusion. Part of protein-DNA complex.
Gene Full Name: nuclear factor, erythroid 2
-
基因ID
- 4778
-
UniProt
- Q16621
抗原
-